Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
2183TSE Standard

Linical Co.,Ltd.

リニカル Yahoo Finance

Recent & upcoming events

Aug 14
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 22
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 15
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Nov 13
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
2027
Feb 12
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
May 14
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Aug 13
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥8.67B YoY -17.0%
Operating income ¥-2.07B margin -23.9%
Net income ¥-3.33B YoY —
EPS ¥-147 YoY —
P/E —
ROE -59.3% Equity ratio 33% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥10.68B +23.2%
Operating income ¥256M —
Net income ¥180M —
EPS ¥8 —

Quarterly fundamentals

Income & cash flow
Quarter FY22 Q4FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1
Revenue ¥3.33B¥3.27B¥3.08B¥2.98B¥3.18B¥3.06B
Operating income ¥367M¥516M¥112M¥309M¥220M¥85M
Net income ¥109M¥427M¥4M¥175M¥75M¥85M
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 32.4%個人 19.6%未開示 45.9%202120222023202420252026
事業法人国内機関海外機関個人その他未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

株式会社秦野 20%株式会社秦野株式会社髙橋 8.9%株式会社髙橋辻本　桂吾 4.5%辻本　桂吾株式会社坂本 3.6%株式会社坂本秦野　和浩 3.3%秦野　和浩髙橋　明宏 3.3%髙橋　明宏高木　幸一 3.2%高木　幸一河合　順 2.7%河合　順宮崎　正哉 2.7%宮崎　正哉公益財団法人マルホ・高木皮膚科学振興 2.1%公益財団法人マルホ・高木皮膚科学振興財団202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
株式会社秦野 4,510,000 20.0% Yuho (EDINET)
株式会社髙橋 2,001,000 8.9% Yuho (EDINET)
辻本 桂吾 1,024,000 4.5% Yuho (EDINET)
株式会社坂本 810,000 3.6% Yuho (EDINET)
秦野 和浩 742,000 3.3% Yuho (EDINET)
髙橋 明宏 741,000 3.3% Yuho (EDINET)
高木 幸一 720,000 3.2% Yuho (EDINET)
河合 順 600,000 2.7% Yuho (EDINET)
宮崎 正哉 600,000 2.7% Yuho (EDINET)
公益財団法人マルホ・高木皮膚科学振興財団 480,000 2.1% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

3/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -27.7%
✗ Positive operating cash flow ¥-1.61B
✗ ROA improved YoY -3.2% → -27.7%
✓ Operating CF exceeds net income (accrual quality) OCF ¥-1.61B / net income ¥-3.33B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 43.2% → 33.1%
✗ Current ratio improved 1.56× → 1.31×
✓ No dilution (shares outstanding did not increase) 24,740,000 → 24,740,000
✗ Gross margin improved 22.8% → 13.0%
✓ Asset turnover improved 0.62× → 0.72×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 33.1%
Current ratio 1.3×
Years of positive operating CF 8 of last 10 yrs
Payout ratio —
Latest fiscal year result Loss (net loss ¥3.33B)

Performance history

Last 10 years
0億円31億円63億円94億円125億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 83.691.111310910311612512310486.7
Operating income 21.318.512.110.14.5310.912.67.26-5.84-20.7
Ordinary income 20.818.312.59.185.8911.812.87.90-4.99-20.2
Net income 14.513.05.684.835.407.9010.03.38-5.39-33.3
Total assets 83.092.5133143153157175185168120
Equity 41.052.052.553.457.165.475.882.472.539.8

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥64¥57¥25¥21¥24¥35¥44¥15¥-24¥-147
ROE 40.7%27.9%10.9%9.1%9.8%12.9%14.2%4.3%-7.0%-59.3%
Operating CF 22.913.6-7.9711.90.2416.318.410.75.95-16.1
Investing CF -3.75-0.92-26.2-1.441.690.21-0.14-0.29-0.450.88
Financing CF -4.57-4.7232.8-9.03-3.30-9.52-9.57-9.61-9.39-5.13
FCF 19.212.7-34.110.51.9316.518.310.45.50-15.2

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data